# From molecular mechanisms to nutritional applications: protein and polyphenol interventions in sarcopenia

**Authors:** Patricia Aragón-Espinosa, Patricia Pérez-Matute, Catherine Bompart, Marine Gueugneau, Frederic Capel, Jose M. Arbones-Mainar, Saioa Gomez-Zorita, Anna Mas-Capdevila, Xavier Escoté, Montserrat Pinent, Anna Ardévol

PMC · DOI: 10.1007/s13105-026-01154-6 · 2026-02-16

## TL;DR

This review discusses how protein and polyphenols can help prevent and manage sarcopenia, a condition causing muscle loss in older adults.

## Contribution

The paper compiles evidence-based nutritional strategies, including novel insights on polyphenols and microbiota, for sarcopenia management.

## Key findings

- Dietary protein is crucial for stimulating muscle protein synthesis in sarcopenia.
- Polyphenols may help preserve muscle through antioxidant and anti-inflammatory effects.
- Emerging research suggests the microbiota could be a new target for sarcopenia interventions.

## Abstract

Sarcopenia, the progressive loss of skeletal muscle mass and function, represents a major public health concern due to its impact on mobility, independence, and quality of life, especially in oldadults. Current treatment strategies primarily rely on resistance training and nutritional support, with particular emphasis on adequate protein intake to stimulate muscle protein synthesis. In this review, we provide an overview of the pathophysiology of sarcopenia, with a focus on the molecular mechanisms underlying muscle atrophy and dysfunction. We explore the role of dietary protein as a cornerstone of sarcopenia management, highlighting current evidence on optimal protein sources and intake strategies. In addition, we examine other nutritional interventions, placing special emphasis on polyphenols, naturally occurring compounds known for their antioxidant and anti-inflammatory properties, which have shown promise in modulating pathways relevant to muscle preservation. Vitamin D and other nutritional supplements are also discussed in the context of their potential to support muscle health. Finally, we address emerging trends in the field, including targeting microbiota. By integrating current findings, this narrative review aims to provide a compilation of the evidence-based nutritional interventions for the prevention and management of sarcopenia.

## Full-text entities

- **Genes:** MSTN (myostatin) [NCBI Gene 2660] {aka GDF8, MSLHP}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, Ppargc1a (peroxisome proliferative activated receptor, gamma, coactivator 1 alpha) [NCBI Gene 19017] {aka A830037N07Rik, Gm11133, PGC-1, PPARGC-1-alpha, Pgc-1alpha, Pgc1}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1) [NCBI Gene 1978] {aka 4E-BP1, 4EBP1, BP-1, PHAS-I}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, PRDX6 (peroxiredoxin 6) [NCBI Gene 9588] {aka 1-Cys, AOP2, HEL-S-128m, LPCAT-5, NSGPx, PRX}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, PLA2G1B (phospholipase A2 group IB) [NCBI Gene 5319] {aka PLA2, PLA2A, PPLA2}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, RPS6KB1 (ribosomal protein S6 kinase B1) [NCBI Gene 6198] {aka PS6K, S6K, S6K-beta-1, S6K1, STK14A, p70 S6KA}, CAT (catalase) [NCBI Gene 847]
- **Diseases:** fatigue (MESH:D005221), atrophy of type II (MESH:D014897), vitamin D (MESH:D014808), of independence (MESH:D064129), obese (MESH:D009765), decline in muscle mass (MESH:C536030), frailty (MESH:D000073496), skeletal muscle disorder (MESH:D005207), inactivity (MESH:C564765), fractures (MESH:D050723), Sarcopenic muscle (MESH:D019042), Mitochondrial dysfunction (MESH:D028361), neurodegeneration (MESH:D019636), II muscle (MESH:D009133), Chronic inflammation (MESH:D007249), Sarcopenia (MESH:D055948), age-related degeneration (MESH:D008268), atrophy (MESH:D001284), functional decline (MESH:D060825), muscle weakness (MESH:D018908), Anabolic resistance (MESH:D060467), impaired muscle function (MESH:D009135), muscle pain (MESH:D063806), abnormalities in amino acid metabolism (MESH:D000592), muscle degeneration (MESH:D009410), loss of lean body mass (MESH:D013851), chronic disease (MESH:D002908), motor dysfunction (MESH:D000068079), apparent (MESH:C536023), Deficiencies (MESH:D007153), muscle hypertrophy (MESH:C536106), iAA (OMIM:617082), dehydration (MESH:D003681), age-related decline (MESH:D010024), hypertrophy (MESH:D006984)
- **Chemicals:** catechol (MESH:C034221), Phenolic acids (MESH:C017616), iron (MESH:D007501), catechin (MESH:D002392), MitoQ (MESH:C429014), apigenin (MESH:D047310), leucine (MESH:D007930), BCAA (MESH:D000597), Resveratrol (MESH:D000077185), essential amino acids (MESH:D000601), copper (MESH:D003300), oxygen (MESH:D010100), (-)-epigallocatechin gallate (MESH:C045651), Vitamin D (MESH:D014807), Stilbenes (MESH:D013267), rutin (MESH:D012431), n-3 polyunsaturated fatty acids (MESH:D015525), nitrogen (MESH:D009584), lipids (MESH:D008055), Polyphenols (MESH:D059808), glutathione (MESH:D005978), Flavonoids (MESH:D005419), short chain fatty acids (MESH:D005232), ROS (MESH:D017382), calcium (MESH:D002118), lysine (MESH:D008239), PUFAs (MESH:D005231), sulfur amino acids (MESH:D000603), Caloric (-), curcumin (MESH:D003474), creatine (MESH:D003401), butyrate (MESH:D002087), Lignans (MESH:D017705), phenoxyl radicals (MESH:C042329), AA (MESH:D000596)
- **Species:** Juglans (walnuts, genus) [taxon 16718], Malus domestica (apple, species) [taxon 3750], Olea (olives, genus) [taxon 4145], Mus musculus (house mouse, species) [taxon 10090], Camellia sinensis (black tea, species) [taxon 4442], Sesamum indicum (beniseed, species) [taxon 4182], Rodentia (rodent, order) [taxon 9989], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12909418/full.md

---
Source: https://tomesphere.com/paper/PMC12909418